Meridian Medica — Cinnamon

01

Identity

Botanical Profile

Cinnamomum verum J.Presl (syn. C. zeylanicum) — Inner bark (dried quills/sticks and powder). Native to Sri Lanka (Ceylon); cultivated in Sri Lanka, Madagascar, Seychelles, and southern India. Cinnamomum verum (Ceylon/true cinnamon) is distinguished from Cinnamomum cassia (Chinese cinnamon/cassia)

Bark: warm, sweet, complex, gently spicy with delicate floral notes. Ceylon cinnamon is lighter, more nuanced, and less pungent than cassia. Quills are thin, multi-layered, and easily crumbled. Powder is light tan-brown (cassia is darker reddish-brown). Aroma is sweet, warm, and inviting without the harsh bite of cassia.

Species Integrity

CRITICAL DISTINCTION: Cinnamomum verum (Ceylon/true cinnamon) and Cinnamomum cassia (Chinese cinnamon) are often sold interchangeably but have significantly different safety profiles. Cassia contains 1–5% coumarin (hepatotoxic at chronic high doses); Ceylon contains 0.004% coumarin (negligible). For daily therapeutic use, ONLY Ceylon cinnamon is appropriate.

02

Compounds

Active Compound Profile

Cinnamaldehyde

65–80% of essential oil (0.5–1.5% of bark)

TRPA1 agonist; antimicrobial (broad-spectrum); NF-κB inhibitor; insulin-mimetic via GLUT4 translocation and insulin receptor phosphorylation

Cinnamyl acetate

5–10% of essential oil

Antiplatelet activity; mild anti-inflammatory; contributes to sweet aromatic profile

Proanthocyanidins (Type-A)

8–12% of bark extract

Insulin-mimetic; potentiate insulin receptor activity; antioxidant; inhibit advanced glycation end-products (AGEs)

Eugenol

5–18% of essential oil in Ceylon (trace in cassia)

COX-2 inhibitor; analgesic; antioxidant; antimicrobial; TRPV1 agonist

Coumarin

0.004% in Ceylon cinnamon; 1–5% in cassia

Hepatotoxic at chronic high doses; anticoagulant precursor (though coumarin itself is not a blood thinner, it is metabolized to hepatotoxic compounds)

Absorption

Fat co-administration: Cinnamaldehyde and essential oil compounds are lipophilic; fat vehicle enhances absorption and reduces GI irritation from concentrated cinnamon

03

Pathways

Mechanism of Action

★★★☆☆ Insulin Receptor Potentiation / GLUT4 Translocation Cinnamon proanthocyanidins and cinnamaldehyde mimic insulin signaling: activating insulin receptor autophosporylation, increasing GLUT4 translocation to cell membranes, and enhancing cellular glucose uptake independent of insulin

★★★☆☆ NF-κB / Anti-Inflammatory Axis Cinnamaldehyde inhibits NF-κB activation by blocking IKK-β phosphorylation; reduces downstream TNF-α, IL-6, COX-2, and iNOS expression

★★★☆☆ Advanced Glycation End-Product (AGE) Inhibition Cinnamon polyphenols inhibit formation of AGEs by trapping reactive carbonyl intermediates (methylglyoxal, glyoxal)

★★★☆☆ Antimicrobial / Gut Pathogen Modulation Cinnamaldehyde has broad-spectrum antimicrobial activity against bacteria (including H. pylori, E. coli), fungi (Candida species), and parasites; disrupts biofilm formation

★★★☆☆ TRPA1 / Warming Thermogenic Cinnamaldehyde activates TRPA1 receptors, producing warming sensation and mild thermogenic effect; complementary to TRPV1 activation by capsaicin

04

Biomarkers

What It Moves in Your Labs

Biomarker	Direction	Target	Mechanism
Fasting Glucose	↓ Decrease	<100 mg/dL	Insulin-mimetic proanthocyanidins enhance cellular glucose uptake via GLUT4 translocation; cinnamaldehyde improves insulin receptor sensitivity
HbA1c	↓ Decrease	<5.7%	Sustained glycemic improvement from daily insulin-sensitizing effect; AGE inhibition reduces glycation of hemoglobin
Triglycerides	↓ Decrease	<100 mg/dL	Enhanced fatty acid oxidation and improved insulin sensitivity reduce hepatic triglyceride synthesis
hs-CRP	↓ Decrease	<1.0 mg/L	NF-κB inhibition by cinnamaldehyde reduces hepatic CRP production

05

Extraction

Extraction & Preparation

Ground powder (food addition): 95%+ all compounds when freshly ground

Solubility · Lipophilic; poorly water-soluble; very soluble in ethanol and oilsMenstruum · 70% ethanol / 30% waterPlant material · Ceylon cinnamon bark (Cinnamomum verum), coarsely ground or broken quillsMaceration time · 4–6 weeks (agitate daily)Ratio · 1:5 (dried bark)

07

Dosing

Dosing Framework

Take cinnamon WITH or immediately before meals for maximum glycemic benefit — the insulin-sensitizing effect acts on the postprandial glucose response.

Dose 1

Culinary: 1/2–1 tsp (1–3g) daily

Easily achieved by adding cinnamon to morning oatmeal and evening Golden Milk

Dose 2

Therapeutic: 1–2 tsp (3–6g) daily

Divide into 2–3 doses with meals; this is the range used in most positive clinical trials

Dose 3

Tincture: 2–4 mL, 2–3x daily

Convenient for precise dosing; take before or with meals for glycemic timing

08

Synergies

Synergy Partners

★★★☆☆ Turmeric (Curcuma longa) Curcumin NF-κB inhibition + cinnamaldehyde NF-κB inhibition = complementary anti-inflammatory pathways; both enhanced by piperine bioavailability multiplication

★★★☆☆ Oats (Avena sativa) Oat beta-glucan glycemic modulation + cinnamon insulin sensitization = dual-mechanism blood sugar management in a single breakfast

★★★☆☆ Ginger (Zingiber officinale) Ginger TRPV1 warming + cinnamon TRPA1 warming = complementary thermogenic pathways; combined NF-κB inhibition

★★★☆☆ Chromium-rich foods (broccoli, grape juice) Chromium enhances insulin receptor sensitivity + cinnamon proanthocyanidins potentiate insulin signaling = synergistic insulin sensitization

★★★☆☆ Fenugreek (Trigonella foenum-graecum) Fenugreek 4-hydroxyisoleucine insulin secretagogue + cinnamon insulin sensitizer = complementary mechanisms addressing both insulin production and insulin action

Signature Stack

THE GLYCEMIC MANAGEMENT TRIO
Components: Ceylon Cinnamon (bark) + Oats (beta-glucan fiber) + Berberine-containing herb (Barberry or Oregon Grape) · Multi-pathway convergence: Insulin receptor potentiation (cinnamon) + Glucose absorption slowing (oat beta-glucan) + AMPK activation and hepatic glucose output reduction (berberine) · The Glycemic Management Trio addresses insulin resistance and blood sugar dysregulation from three complementary mechanisms. This is particularly relevant for Hashimoto's patients, who have a significantly elevated risk of developing type 2 diabetes. · Practical integration: Cinnamon oatmeal for breakfast (cinnamon + oats); berberine-containing herb tincture or tea with meals. Simple, sustainable, food-based glycemic management.

09

Safety

Contraindications & Interactions

Minor Cassia vs. Ceylon (coumarin hepatotoxicity) Cassia cinnamon contains 1–5% coumarin; the European Food Safety Authority (EFSA) Tolerable Daily Intake for coumarin is 0.1mg/kg body weight. At 6g/day cassia, a 60kg person would exceed TDI by 6–30x. Ceylon contains negligible coumarin (0.004%).

Avoid Pregnancy (high doses) Cinnamaldehyde may stimulate uterine contractions at high doses. Traditional use of culinary cinnamon during pregnancy is universal and safe. High-dose supplementation should be avoided.

Minor Anticoagulant interaction (cassia only) Coumarin in cassia may potentiate warfarin. Ceylon cinnamon's negligible coumarin makes this a non-issue for verum species.

Minor Hypoglycemia risk Cinnamon's insulin-sensitizing effect could theoretically cause hypoglycemia when combined with insulin or sulfonylurea medications, particularly at higher therapeutic doses.

Minor Contact sensitivity (cinnamaldehyde) Cinnamaldehyde is a known contact allergen; cinnamon essential oil can cause skin irritation. Oral mucosal irritation possible with cinnamon gum or concentrated preparations.

11

Evidence

Evidence Base

★★★★☆ Glycemic Regulation (Fasting Glucose, HbA1c) Strong — Multiple meta-analyses with significant effect sizes

★★★☆☆ Lipid Improvement Moderate — Consistent direction; variable effect sizes

★★★☆☆ Antimicrobial Activity Moderate — Strong in vitro data; limited clinical trials

★★★☆☆ Anti-Inflammatory (Systemic) Moderate — Well-characterized mechanism; emerging human data

★★☆☆☆ Neuroprotective / Cognitive Preliminary — Promising animal data; limited human studies

Evidence Gaps

The highest-value research gap for Meridian Medica: no published RCT has evaluated daily Ceylon cinnamon supplementation specifically in Hashimoto's patients with comorbid insulin resistance. Given that insulin resistance occurs in approximately 50% of Hashimoto's patients and cinnamon's insulin-sensitizing effects are well-documented in type 2 diabetes, a trial measuring fasting insulin, HOMA-IR, fasting glucose, HbA1c, and thyroid biomarkers in Hashimoto's women with confirmed insulin resistance before and after 12 weeks of 3g/day Ceylon cinnamon would directly test this clinical intersection.

Quality Alert

Cinnamon has one of the highest adulteration and misidentification rates of any spice:

12

Protocol

Protocol Integration

Layer 1: Hypothalamic / Autonomic — HPA axis, circadian rhythm, stress response

Layer 2: Systemic Nutritional Repletion — Micronutrient optimization, antioxidant defense

Layer 3: Gut Permeability / Microbiome — Tight junction repair, motility, SIBO management

Recipe Integration

Morning Cinnamon Oatmeal

1 tsp (2g) Ceylon cinnamon in 1.5 cups cooked oatmeal

Feed the Markers

Cinnamon appears in the following Meridian Medica protocol contexts: